Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 New Entrants companies in Nicotinamide mononucleotide
by Most Patent Filing In 5 Years in the United States in 2022

The Nicotinamide mononucleotide top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filing In 5 Years Nicotinamide mononucleotide New Entrants in the United States. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Nicotinamide mononucleotide ("NMN", "NAMN", and "β-NMN") is a nucleotide derived from ribose and nicotinamide. Like nicotinamide riboside, NMN is a derivative of niacin, and humans have enzymes that can use NMN to generate nicotinamide adenine dinucleotide (NADH).
#
Company Name
Region
Tech Topics
Total
1
Life BioScience, Inc.
Patent: 11
2
Bioenergy Life Science, Inc.
Clinical trial,Biotechnology
Patent: 4
3
JumpStart Fertility, Inc.
Health care,Fertility
Patent: 3
4
University of Pittsburgh
Graduate degree,Academic Training,The Internet,
...[+2]
Patent: 2
5
Conagen, Inc.
Biology,Chemical engineering,Medicine,
...[+2]
Patent: 1
Page generation time: Jun 20 2025